CD38 and ischemic stroke: The depletion of NAD+ after ischemic stroke can lead to cell death and is associated with the excessive activation of poly-ADP-ribose polymerase (PARP1), as well as an increase in the CD38 enzyme, which consumes NAD+ [42].